vs
Side-by-side financial comparison of DNA X, Inc. (SONM) and SS Innovations International, Inc. (SSII). Click either name above to swap in a different company.
DNA X, Inc. is the larger business by last-quarter revenue ($16.2M vs $14.5M, roughly 1.1× SS Innovations International, Inc.). SS Innovations International, Inc. runs the higher net margin — -17.0% vs -29.3%, a 12.3% gap on every dollar of revenue. On growth, SS Innovations International, Inc. posted the faster year-over-year revenue change (79.1% vs 7.9%). Over the past eight quarters, SS Innovations International, Inc.'s revenue compounded faster (99.9% CAGR vs 9.9%).
SS Innovations International, Inc. is a global medical technology enterprise specializing in the research, development and manufacturing of innovative surgical robotic systems. It provides high-precision, accessible robotic platforms for minimally invasive surgery, catering to healthcare facilities across multiple regions to boost surgical outcomes and cut procedural burdens.
SONM vs SSII — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $16.2M | $14.5M |
| Net Profit | $-4.8M | $-2.5M |
| Gross Margin | 11.2% | 43.9% |
| Operating Margin | -24.5% | -3.7% |
| Net Margin | -29.3% | -17.0% |
| Revenue YoY | 7.9% | 79.1% |
| Net Profit YoY | -89.2% | -28.5% |
| EPS (diluted) | $-4.83 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $14.5M | ||
| Q3 25 | $16.2M | $12.8M | ||
| Q2 25 | $11.2M | $10.0M | ||
| Q1 25 | $16.7M | $5.1M | ||
| Q4 24 | $15.3M | $8.1M | ||
| Q3 24 | $15.0M | $4.4M | ||
| Q2 24 | $11.5M | $4.5M | ||
| Q1 24 | $9.1M | $3.6M |
| Q4 25 | — | $-2.5M | ||
| Q3 25 | $-4.8M | $-3.7M | ||
| Q2 25 | $-7.5M | $-256.7K | ||
| Q1 25 | $458.0K | $-5.7M | ||
| Q4 24 | $-21.6M | $-1.9M | ||
| Q3 24 | $-2.5M | $-3.2M | ||
| Q2 24 | $-6.6M | $-4.1M | ||
| Q1 24 | $-2.9M | $-9.8M |
| Q4 25 | — | 43.9% | ||
| Q3 25 | 11.2% | 48.1% | ||
| Q2 25 | 7.6% | 59.1% | ||
| Q1 25 | 50.0% | 21.2% | ||
| Q4 24 | -1.2% | 48.9% | ||
| Q3 24 | 28.2% | 52.8% | ||
| Q2 24 | 25.8% | 31.9% | ||
| Q1 24 | 31.8% | 20.0% |
| Q4 25 | — | -3.7% | ||
| Q3 25 | -24.5% | -14.3% | ||
| Q2 25 | -60.2% | 1.0% | ||
| Q1 25 | 3.9% | -115.6% | ||
| Q4 24 | 55.3% | -22.7% | ||
| Q3 24 | -15.8% | -73.1% | ||
| Q2 24 | -56.2% | -90.9% | ||
| Q1 24 | -29.5% | -270.3% |
| Q4 25 | — | -17.0% | ||
| Q3 25 | -29.3% | -29.0% | ||
| Q2 25 | -66.8% | -2.6% | ||
| Q1 25 | 2.7% | -111.0% | ||
| Q4 24 | -141.6% | -23.7% | ||
| Q3 24 | -16.7% | -74.0% | ||
| Q2 24 | -57.5% | -91.8% | ||
| Q1 24 | -31.9% | -270.5% |
| Q4 25 | — | $-0.01 | ||
| Q3 25 | $-4.83 | $-0.02 | ||
| Q2 25 | $-0.79 | $0.00 | ||
| Q1 25 | $0.08 | $-0.03 | ||
| Q4 24 | $-116.99 | $-0.01 | ||
| Q3 24 | $-9.32 | $-0.02 | ||
| Q2 24 | $-1.41 | $-0.02 | ||
| Q1 24 | $-0.65 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.1M | $3.2M |
| Total DebtLower is stronger | $5.1M | — |
| Stockholders' EquityBook value | $-701.0K | $38.2M |
| Total Assets | $40.2M | $74.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $3.2M | ||
| Q3 25 | $2.1M | $5.7M | ||
| Q2 25 | $2.0M | $11.4M | ||
| Q1 25 | $2.1M | $15.9M | ||
| Q4 24 | $5.3M | $466.5K | ||
| Q3 24 | $9.1M | $220.4K | ||
| Q2 24 | $9.6M | $608.2K | ||
| Q1 24 | $9.3M | $948.1K |
| Q4 25 | — | — | ||
| Q3 25 | $5.1M | — | ||
| Q2 25 | $2.9M | — | ||
| Q1 25 | $2.8M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $38.2M | ||
| Q3 25 | $-701.0K | $39.6M | ||
| Q2 25 | $-1.3M | $42.0M | ||
| Q1 25 | $-1.1M | $40.6M | ||
| Q4 24 | $-5.7M | $13.5M | ||
| Q3 24 | $15.3M | $13.7M | ||
| Q2 24 | $17.5M | $14.8M | ||
| Q1 24 | $19.8M | $16.7M |
| Q4 25 | — | $74.2M | ||
| Q3 25 | $40.2M | $69.6M | ||
| Q2 25 | $36.1M | $70.0M | ||
| Q1 25 | $36.0M | $63.5M | ||
| Q4 24 | $39.7M | $42.4M | ||
| Q3 24 | $49.1M | $39.0M | ||
| Q2 24 | $45.9M | $35.7M | ||
| Q1 24 | $42.4M | $35.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-7.0M | $-1.5M |
| Free Cash FlowOCF − Capex | — | $-3.2M |
| FCF MarginFCF / Revenue | — | -22.3% |
| Capex IntensityCapex / Revenue | — | 11.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-22.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-1.5M | ||
| Q3 25 | $-7.0M | $-7.5M | ||
| Q2 25 | $-4.9M | $-3.5M | ||
| Q1 25 | $-9.6M | $-6.1M | ||
| Q4 24 | $-4.5M | $-3.3M | ||
| Q3 24 | $-417.0K | $-2.5M | ||
| Q2 24 | $-3.4M | $-1.0M | ||
| Q1 24 | $-168.0K | $-2.7M |
| Q4 25 | — | $-3.2M | ||
| Q3 25 | — | $-8.2M | ||
| Q2 25 | — | $-3.8M | ||
| Q1 25 | — | $-7.0M | ||
| Q4 24 | $-4.5M | $-3.4M | ||
| Q3 24 | $-554.0K | $-4.2M | ||
| Q2 24 | $-3.4M | $-3.1M | ||
| Q1 24 | $-198.0K | $-2.8M |
| Q4 25 | — | -22.3% | ||
| Q3 25 | — | -64.1% | ||
| Q2 25 | — | -37.7% | ||
| Q1 25 | — | -136.2% | ||
| Q4 24 | -29.6% | -41.7% | ||
| Q3 24 | -3.7% | -96.9% | ||
| Q2 24 | -29.8% | -69.5% | ||
| Q1 24 | -2.2% | -76.9% |
| Q4 25 | — | 11.8% | ||
| Q3 25 | — | 5.9% | ||
| Q2 25 | — | 3.2% | ||
| Q1 25 | — | 17.0% | ||
| Q4 24 | 0.1% | 1.5% | ||
| Q3 24 | 0.9% | 38.8% | ||
| Q2 24 | 0.3% | 46.8% | ||
| Q1 24 | 0.3% | 3.5% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -20.97× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SONM
Segment breakdown not available.
SSII
| System Sales | $13.4M | 92% |
| Other | $1.2M | 8% |
